Your browser doesn't support javascript.
loading
Erratum to "Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project": [Annals of Oncology 32 (2021) 1626-1636].
Vega, D M; Yee, L M; McShane, L M; Williams, P M; Chen, L; Vilimas, T; Fabrizio, D; Funari, V; Newberg, J; Bruce, L K; Chen, S-J; Baden, J; Carl Barrett, J; Beer, P; Butler, M; Cheng, J-H; Conroy, J; Cyanam, D; Eyring, K; Garcia, E; Green, G; Gregersen, V R; Hellmann, M D; Keefer, L A; Lasiter, L; Lazar, A J; Li, M-C; MacConaill, L E; Meier, K; Mellert, H; Pabla, S; Pallavajjalla, A; Pestano, G; Salgado, R; Samara, R; Sokol, E S; Stafford, P; Budczies, J; Stenzinger, A; Tom, W; Valkenburg, K C; Wang, X Z; Weigman, V; Xie, M; Xie, Q; Zehir, A; Zhao, C; Zhao, Y; Stewart, M D; Allen, J.
Affiliation
  • Vega DM; Friends of Cancer Research, Washington.
  • Yee LM; National Cancer Institute, Bethesda.
  • McShane LM; National Cancer Institute, Bethesda.
  • Williams PM; Molecular Characterization Laboratory, Frederick National Lab for Cancer Research, Leidos Biomedical Research Inc., Frederick.
  • Chen L; Molecular Characterization Laboratory, Frederick National Lab for Cancer Research, Leidos Biomedical Research Inc., Frederick.
  • Vilimas T; Molecular Characterization Laboratory, Frederick National Lab for Cancer Research, Leidos Biomedical Research Inc., Frederick.
  • Fabrizio D; Foundation Medicine Inc., Cambridge.
  • Funari V; NeoGenomics Laboratories, Aliso Viejo, USA.
  • Newberg J; Foundation Medicine Inc., Cambridge.
  • Bruce LK; NeoGenomics Laboratories, Aliso Viejo, USA.
  • Chen SJ; ACT Genomics, Taipei, Taiwan.
  • Baden J; Bristol Myers Squibb Co., Princeton.
  • Carl Barrett J; AstraZeneca Pharmaceuticals LP, Waltham, USA.
  • Beer P; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • Butler M; LGC Clinical Diagnostics, Gaithersburg.
  • Cheng JH; ACT Genomics, Taipei, Taiwan.
  • Conroy J; OmniSeq Inc., Buffalo.
  • Cyanam D; Clinical Sequencing Division, Thermo Fisher Scientific, Ann Arbor.
  • Eyring K; Intermountain Precision Genomics, St. George.
  • Garcia E; Brigham and Women's Hospital, Boston, USA.
  • Green G; Bristol Myers Squibb Co., Princeton.
  • Gregersen VR; QIAGEN Inc, Aarhus, Denmark.
  • Hellmann MD; Memorial Sloan Kettering Cancer Center, New York.
  • Keefer LA; Personal Genome Diagnostics, Baltimore.
  • Lasiter L; Friends of Cancer Research, Washington.
  • Lazar AJ; The University of Texas MD Anderson Cancer Center, Houston.
  • Li MC; National Cancer Institute, Bethesda.
  • MacConaill LE; Brigham and Women's Hospital, Boston, USA.
  • Meier K; Illumina Inc, Clinical Genomics, San Diego.
  • Mellert H; Biodesix, Inc., Boulder.
  • Pabla S; OmniSeq Inc., Buffalo.
  • Pallavajjalla A; Johns Hopkins University, Baltimore.
  • Pestano G; Biodesix, Inc., Boulder.
  • Salgado R; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • Samara R; QIAGEN Inc, Aarhus, Denmark.
  • Sokol ES; Foundation Medicine Inc., Cambridge.
  • Stafford P; Caris Life Sciences Inc, Phoenix, Arizona, USA.
  • Budczies J; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Tom W; Clinical Sequencing Division, Thermo Fisher Scientific, Ann Arbor.
  • Valkenburg KC; Personal Genome Diagnostics, Baltimore.
  • Wang XZ; EMD Serono Research and Development Institute, Inc., Billerica.
  • Weigman V; Q Squared Solutions, Durham.
  • Xie M; AstraZeneca Pharmaceuticals LP, Waltham, USA.
  • Xie Q; General Dynamics Information Technology, Inc., Columbia, USA.
  • Zehir A; Memorial Sloan Kettering Cancer Center, New York.
  • Zhao C; Illumina Inc, Clinical Genomics, San Diego.
  • Zhao Y; National Cancer Institute, Bethesda.
  • Stewart MD; Friends of Cancer Research, Washington. Electronic address: mstewart@focr.org.
  • Allen J; Friends of Cancer Research, Washington.
Ann Oncol ; 35(1): 145, 2024 Jan.
Article in En | MEDLINE | ID: mdl-37558578
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Diagnostic_studies Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2024 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Diagnostic_studies Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2024 Type: Article